Roxadustat for treating anemia and improving bone and mental health in hemodialysis patients
Official title: Effect of Roxadustat on Bone and Neuropsychiatric Aspects in End Stage Kidney Disease Patients on Hemodialysis
Run by Mansoura University · NCT06917950 · Data updated 2026-11-12
This study is testing if the medication Roxadustat can help improve anemia, bone health, and mental well-being in patients on hemodialysis for kidney disease.
Quick facts
| Phase | Phase1; Phase2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 46 (estimated) |
| Sponsor | Mansoura University Academic / other |
| Locations | 1 site (Al Mansurah, Dakahliya) |
| Status | Recruiting |
| Started | April 15, 2025 |
| Main results expected | October 15, 2025 |
| Study ends | November 1, 2025 |
| Registry record updated | May 11, 2025 |
| Trial ID | NCT06917950 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old with end-stage kidney disease on chronic hemodialysis for more than three months.
✕Probably not a fit
Patients who are pregnant, have malignancies, or have other specific hematological disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effects of Roxadustat, an oral medication, on anemia and its potential benefits for bone health and mental well-being in patients undergoing hemodialysis for end-stage kidney disease. The study aims to assess changes in bone mineral density, psychological symptoms of depression and anxiety, and nerve and muscle function through various tests and questionnaires. A total of 46 patients will be enrolled to evaluate the broader impacts of Roxadustat beyond its primary use for anemia treatment.
Why it matters
Potential benefit: If successful, this study could provide a new treatment option that improves not only anemia but also bone health and mental health for hemodialysis patients.
How similar studies have gone: While Roxadustat has shown promise in treating anemia, its effects on bone and mental health in hemodialysis patients are less explored, making this a novel approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * The age of the patient is more than 18. * Patients who are willing to sign informed consent. * Patients with ESKD on chronic hemodialysis for more than 3 months. Exclusion Criteria: * Current pregnancy or lactation. * Patients with pre-existing malignancy. * patients with psychosis. * Known history of hematological disorders or other causes of anemia other than CKD. * Taking medications that may significantly affect or interact with bone metabolism such as osteo-anabolics or bone resorptives during the last 6 months.
Where it's running
-
Urology and Nephrology Center, Mansoura University
Al Mansurah, Dakahliya, Egypt Recruiting
Study contacts
- Study coordinator: Mostafa I Alaskary, M.Sc
- Email: drmostafa2110@gmail.com
- Phone: +201017178892
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Exergames-acceptance and Commitment Therapy for Breast Cancer Depression and Anxiety
This trial tests whether a combined exergame-based program with acceptance and commitment therapy helps reduce depression and anxiety in breast cancer survivors compared with ACT alone or standard care.
-
Group-based ACT for psychological distress in young people
Researchers are testing whether group-based ACT helps 16-25 year olds with depression or anxiety more than the usual individual therapy.
-
How controlled sounds and sensory stimulation affect the brain in an acoustic chamber
This project will test how controlled sensory stimulation, such as music, changes brain activity and behavior in adults with epilepsy and in healthy volunteers.
-
Home-based exercise to boost fitness for people waiting for a kidney transplant
This study tests whether a 12-week, home-based exercise program plus a wearable activity tracker helps adults on the kidney transplant waiting list increase daily activity and improve physical function.
-
How insomnia develops during the first year after a new cancer diagnosis
This project will track how insomnia appears and changes during the first year after a cancer diagnosis in adults who had no prior sleep problems.
-
Mental Health CPR to support emotional health of Hispanic/Latino cancer survivors
This program tests whether Mental Health CPR helps Hispanic/Latino cancer survivors in Puerto Rico complete distress screening and connect with psycho-oncology services.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.